Pharmaceutical-Grade Deep-Hiav txwv Salmon PDRN (DNA Sodium) Hmoov
Tau qhov twg los: Deep-Hiav txwv Salmon (sib txawv ntawm qhov sib sib zog nqus sib sib zog nqus- hiav txwv trout)
Assay Standard: Ntau dua lossis sib npaug rau 99.0%
Extraction Part: Salmon milt / phev hnab
Molecular Nyhav Fragments: 80-100bp, 200-250bp
Protein Impurity Limit: Tsawg dua lossis sib npaug li 1.0%
Cia Cia: Cia txias ntawm 2-8 degree
Lub neej txee: 24 Lub Hlis
Core Biological Mechanisms
1. A2A Adenosine Receptor Activation
PDRN tshwj xeeb lub hom phiaj thiab ua kom lub A2A receptor txoj kev. Qhov kev cuam tshuam tseem ceeb no ua rau muaj kev cuam tshuam ntawm cov lus teb rov qab: nws nquaginhibits inflammatory markers, upregulates yam tseem ceeb loj hlob, thiabtxhawb nqa angiogenesis (cov hlab ntsha tshiab). Cov txheej txheem no ua rau cov ntaub so ntswg rov tsim dua tshiab thiab kho kev puas tsuaj.
2. Txoj Kev Txuag Nucleotide
Thaum metabolized, lub hauv paus thiab nucleosides tsim los ntawm PDRN tau zoo rov qab los ntawm txoj hauv kev biochemical khaws cia. Cov fragments no ncaj qha reintegrated rau hauv cellular DNA, sai sai reactivating ib txwm cellular proliferation thiab ua kom lub qhov txhab zoo thiab cov ntaub so ntswg reconstruction.
Hauv -Vitro Assays & Clinical Validation
Fibroblast & Collagen Stimulation
Hauv kev soj ntsuam ntawm tes siv tib neeg daim tawv nqaij Fibroblasts (HSF), peb PDRN tau qhia txog kev ua haujlwm lom neeg zoo tshaj. Cov txheeb ze ntawm cov cell proliferation tau nce mus rau104.80%. Tsis tas li ntawd, nws tau txhawb nqa qhov tso tawm ntawm cov protein ntau ntawm cov cellular matrix, txhawb hom I Collagen rau114.42%thiab hom III Collagen rau116.70%.
Muaj zog Anti-Inflammatory Action
Hauv RAW264.7 macrophage qauv, peb tus qauv PDRN extract tau txo qis pro-inflammatory cytokines, txo qis IL-6 secretion rau77.90%thiab TNF- rau85.00%. Tib lub sijhawm, nws tau tswj hwm cov tshuaj tiv thaiv - mob cytokine IL-10 rau131.20%, tsim kom muaj kev tiv thaiv zoo - inflammatory kev ua tau zoo.
Dermatological Clinical Efficacy
Randomized ob - qhov muag tsis pom kev soj ntsuam kev sim ua pov thawj muaj txiaj ntsig zoo los tiv thaiv- kev laus. Tom qab 28 hnub ntawm kev thov,dermal ntom ntom tau nce 8.67%. Cov kev ntsuam xyuas tshwj xeeb tau pom tias txo qis hauv cheeb tsam ko taw los ntawm 10.31%, hauv qab - qhov muag wrinkles suav los ntawm 27.06%, thiab kua muag trough ntim los ntawm 18.11%.
Sunburn Kho & Acne Control
Raws li UV-cov qauv tsim kev puas tsuaj, 0.5% PDRN cov tshuaj txo qis Trans-Epidermal Water Loss (TEWL) los ntawm14.3%thiab txo cov tawv nqaij liab (a* tus nqi) los ntawm20.33%. Hauv pob txuv- cov neeg mob uas muaj kab mob, qhov chaw pob txuv tau poob los ntawm qhov zoo kawg li59.23%nrog rau 16.81% txo qis hauv comedones.
Pharmaceutical -Qib Kev Tswj Xyuas
PDRN Qib Specifications
| Daim ntawv khoom | Ntsiab Specifications & Features | Lub Hom Phiaj Qib / Daim Ntawv Thov |
|---|---|---|
| 1. hmoov | Cov ntsiab lus Protein <1.0% (Tested <0.05%) | Cosmetic Grade / Food Grade |
| 2. Lyophilized (Txias-Kub) | Zero Protein, Deionized | Premium Cosmetic Qib |
| 3. Hmoov (Ultra-Pure) | Endotoxin <0.5EU (Customizable rau <0.05EU) | Chav Kawm II/III Kho Mob Qib Qib |
| 4. Ua kua | Npaj - los - siv Aqueous PDRN Solution | Versatile Manufacturing Formulation |
Formulation Compatibilities & Cia
Ua kom muaj kev ua haujlwm lom neeg siab tshaj plaws
Kev tawg:Soluble nyob rau hauv dej ntawm chav tsev kub. Peb pom zoo kom ntxiv PDRN maj mam thaum sib nqus nplawm kom tiv thaiv agglomeration.
Incompatibilities:nruj me ntsis txwv tsis pub muaj zog oxidizers, cov khoom muaj zog, cationic ntsev, hydrogen peroxide, siab concentrations ntawm cawv, tannic acid, txiv hmab txiv ntoo acids, thiab citric acid. Kev kub siab ntev yog txwv tsis pub.
Cia:Txhawm rau ua kom muaj kev ncaj ncees, muab ntim rau hauv qhov chaw txias, tsaus nti (txias ntawm 2-8 degree). Cov khoom pov thawj tseeb yog 2 xyoos.
Formulation & Procurement FAQ
Q1: Dab tsi yog qhov hnyav molecular ntawm koj PDRN API?
Los ntawm cov txheej txheem tswj qhov hnyav molecular patented, peb PDRN yog qhov tseeb ntawm 200-250bp (138-165KDa). Qhov no concentrated faib ua kom muaj zog fluorescence siv nyob rau hauv nucleic acid electrophoresis, zoo ib yam viscosity, thiab kev pom kev lom neeg.
Q2: Koj yuav tswj cov protein seem li cas los tiv thaiv kev tsis haum?
Peb siv cov txheej txheem purification siab heev uas txo cov protein seem kom qis dua 0.05%. Validated los ntawm BSA protein electrophoresis, peb PDRN qhia tsis pom cov protein ntau txawm nyob rau hauv siab loading ntim ntawm 800µg, minimizing immunogenicity thiab allergy txaus ntshai heev.
Q3: Yuav ua li cas yog cov formulation incompatibilities rau PDRN?
Formulators yuav tsum tsis txhob muaj cov tshuaj oxidizing muaj zog, cov tshuaj reactive heev, cationic ntsev, hydrogen peroxide, siab concentrations ntawm cawv, tannic acid, txiv hmab txiv ntoo acids, thiab citric acid. Lub sijhawm ntev raug rau qhov kub thiab txias kuj tseem txwv nruj heev.
Cim npe nrov: Pharmaceutical-qib sib sib zog nqus- hiav txwv salmon pdrn (dna sodium) hmoov, Tuam Tshoj kws tshuaj-qib sib sib zog nqus- hiav txwv salmon pdrn (dna sodium) hmoov manufacturers, lwm tus neeg, Hoobkas
You Might Also Like
Xa kev nug